The hemophilia market is expected to experience significant growth due to advancements in gene therapy, innovative treatments, and an increasing focus on personalized medicine. Rising awareness and ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Now that his adult sons manage their own hemophilia care, columnist Joe MacDonald wonders how he can best support them.

for the routine prophylaxis of bleeding episodes in patients 12 years of age and older weighing at least 35 kg with severe hemophilia A (congenital factor VIII [FVIII] deficiency, FVIII <1% ...

Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...

Pfizer’s decision to halt further marketing of Beqvez is further sign of the sparse patient interest in gene therapies for the bleeding condition.

Clopidogrel is a prescription drug used to reduce the risk of heart attack and stroke. Learn about the common, mild, and ...

Ixinity (trenonacog alfa) can effectively prevent and controlled bleeds in young children with severe or moderately severe ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

And daily aspirin may increase their risk of internal bleeding. For example, if 1,000 healthy people took an aspirin daily for about six years: Daily aspirin would prevent three or four serious ...

But a sudden drop in blood pressure could also be a sign of a potentially serious condition like heart problems, heatstroke, or internal bleeding. A sudden drop in blood pressure of just 20 mmHg, such ...